Financhill
Back

Inhibrx Quote, Financials, Valuation and Earnings

Inhibrx Price Quote

$25.75
+0.67 (+2.67%)
(Updated: February 3, 2023 at 6:50 PM ET)

Inhibrx Key Stats

Buy
53
Inhibrx (INBX) is a Buy

Day range:
$24.84 - $26.16
52-week range:
$7.67 - $34.72
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
206.96
P/B ratio:
0%

Volume:
512.3K
Avg. volume:
424.2K
1-year change:
-6.49%
Market cap:
$1.1B
Revenue:
$7.1M
EPS:
$-3.22

How Much Does Inhibrx Make?

  • How Much Are Inhibrx's Sales Annually?
    INBX Revenues are $7.1M
  • How Much Profit Does Inhibrx's Make A Year?
    INBX net income is -$81.8M

Is Inhibrx Growing As A Company?

  • What Is Inhibrx's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.89%
  • What Is Inhibrx's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Inhibrx Stock Price Performance

  • Did Inhibrx Stock Go Up Last Month?
    Inhibrx share price went up by 1.79% last month
  • Did INBX's Share Price Rise Over The Last Year?
    INBX share price fell by -6.49% over the past 1 year

What Is Inhibrx 52-Week High & Low?

  • What Is Inhibrx’s 52-Week High Share Price?
    Inhibrx has traded as high as $34.72 over the past 52 weeks
  • What Is Inhibrx’s 52-Week Low Share Price?
    Inhibrx has traded as low as $7.67 over the past 52 weeks

Inhibrx Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Inhibrx?

  • How Much Debt Does Inhibrx Have?
    Total long term debt quarterly is $170.8M
  • How Much Cash Does Inhibrx Have?
    Cash and short term investments quarterly total is $146.1M
  • What Is Inhibrx’s Book Value Per Share?
    Book value per share is -0.90

Is Inhibrx Cash Flow Positive?

  • What Is INBX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$107.3M
  • What Is Inhibrx’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $141.4M
  • What Is Inhibrx’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$686K

Inhibrx Return On Invested Capital

  • Is Management Doing A Good Job?
    INBX return on invested capital is -95.33%
  • What Is Inhibrx Return On Assets?
    ROA measures how assets are converting to revenues and is -78.55%
  • What Is INBX Return On Equity?
    ROE is a measure of profitability and is -923.32%

Inhibrx Earnings Date & Stock Price

  • What Is Inhibrx's Stock Price Today?
    A single share of INBX can be purchased today for 25.08
  • What Is Inhibrx’s Stock Symbol?
    Inhibrx trades on the nasdaq under the ticker symbol: INBX
  • When Is Inhibrx’s Next Earnings Date?
    The next quarterly earnings date for Inhibrx is scheduled on February 28, 2023
  • When Is INBX's next ex-dividend date?
    Inhibrx's next ex-dividend date is February 4, 2023
  • How To Buy Inhibrx Stock?
    You can buy Inhibrx shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Inhibrx Competitors

  • Who Are Inhibrx's Competitors?
    Below is a list of companies who compete with Inhibrx or are related in some way:
    • CinCor Pharma Inc (CINC)
    • Seres Therapeutics Inc (MCRB)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Silk Road Medical Inc (SILK)
    • Stoke Therapeutics Inc (STOK)

Inhibrx Dividend Yield

Data Unavailable

Inhibrx Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.82%
Revenue: -88.92% -50.94%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 47.50
Upside from Last Price: 89.39%

Major Shareholders

  • How many INBX shares are owned by institutional investors?
    40.3M INBX shares are owned by institutional investors
  • How many INBX shares are owned by insiders?
    215.2K INBX shares are owned by insiders